Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Ministry faulted for delayed response to starfish outbreak on Dongsha
12/28/2025 04:47 PM - Cross-Strait
Taipei mayor calls for 'peace and prosperity' at Shanghai forum
12/28/2025 04:04 PM - Politics
Army trainees complete grueling 10-day Ranger training in Taichung
12/28/2025 03:48 PM - Society
Subduction-zone quake off Yilan produces few aftershocks: CWA
12/28/2025 03:35 PM - Society
Damage from Saturday's earthquake mostly repaired
12/28/2025 02:39 PM